ONCO
NASDAQ
$1
Onconetix Inc (ONCO)
Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions. Utilizing a proprietary technology platform, the company specializes in early detection and personalized treatment for a range of malignancies, addressing key unmet needs in the oncology space. With a strong and diverse product pipeline, Onconetix is well-positioned to capitalize on the increasing demand for effective cancer therapies, aiming to significantly improve patient outcomes through its advanced research and development efforts in this dynamic and rapidly advancing field.
Sector:
Healthcare
Industry:
Biotechnology
Target: $9 (+800.00%)
Market Cap
$2.54M
P/B Ratio
0.27
Price Chart
Valuation
Market Cap$2.54M
P/S3.92
P/B0.27
Profitability
Total Revenue (TTM)$735K
Gross Profit (TTM)$585K
EBITDA-$9.16M
Operating Margin-9749%
EPS-$4.28
Financial Health
Debt-to-Equity2.5%
Growth & Risk
Sharpe Ratio-2.39